Belle-Mead, NJ, United States of America

Victoria K Lombardo

This inventor holds 6 USPTO granted patents and 2 published patent applications. Top assignee: Merck + Co., Inc.. Active years: 1998-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Victoria K Lombardo. Retrieved from https://idiyas.com/inventor/victoria-k-lombardo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 100.0

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 77(Granted Patents)


Location History:

  • Belle Mead, NJ (US) (1998 - 2002)
  • Belle Meade, NJ (US) (2002)

Company Filing History:


Years Active: 1998-2002

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Victoria K Lombardo: Innovator in Diabetes Treatment

Introduction

Victoria K Lombardo is a prominent inventor based in Belle Meade, NJ (US). She has made significant contributions to the field of medicine, particularly in the treatment of diabetes and related conditions. With a total of six patents to her name, Lombardo's work has the potential to impact the lives of many individuals suffering from metabolic disorders.

Latest Patents

Lombardo's latest patents include innovative compounds such as Arylthiazolidinedione derivatives. These substituted 5-aryl-2,4-thiazolidinediones and oxazolidinediones are recognized as potent agonists of PPAR, making them useful in the treatment, control, or prevention of diabetes, hyperglycemia, hyperlipidemia, atherosclerosis, obesity, vascular restenosis, and other PPAR α and/or γ mediated diseases, disorders, and conditions. Another notable patent involves Arylthiazolidinedione and aryloxazolidinedione derivatives, which also carry a second substituent in the 5-position of the heterocyclic ring. These compounds are similarly effective in addressing various metabolic disorders.

Career Highlights

Victoria K Lombardo is currently associated with Merck & Company, Inc., where she continues to advance her research and development efforts. Her work at Merck has positioned her as a key player in the pharmaceutical industry, particularly in the area of drug development for metabolic diseases.

Collaborations

Lombardo has collaborated with notable colleagues such as Soumya P Sahoo and Jeffrey P Bergman. These collaborations have further enhanced her research capabilities and contributed to the success of her innovative projects.

Conclusion

Victoria K Lombardo is a trailblazer in the field of diabetes treatment, with a strong portfolio of patents that reflect her dedication to improving health outcomes. Her contributions to medical science are invaluable, and her ongoing work promises to lead to further advancements in the treatment of metabolic disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…